Why Big Pharma is Investing Billions in This Biotech

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

SPECIAL OPPORTUNITIES Today we're sharing a message from Samantha Tino at Behind the Markets. We thought you may be interested in her offer. - Rachel Gearhart, Publisher Why Big Pharma is Investing Billions in This Biotech Dear Reader, If you're on the hunt for a great biotech stock under $20... you need to see this video. This tiny biotech has achieved something remarkable. They're revolutionizing healthcare with a radical treatment that could help as many as 50 million people... and save the U.S. $20 trillion in medical costs. Here's the deal: this company figured out how to use a "Drug Smuggler" to help treat Alzheimer's and Parkinson's. This is HUGE. Right now, Big Pharma sells $16 billion worth of Alzheimer's drugs that don't even make it to the brain! But now, this company is developing a platform that could allow for the cure of nearly all neurodegenerative diseases - like Alzheimer's, Parkinson's, and ALS. The Economist says this would be a "boon to humanity." Even Jeff Bezos has invested $130 million into this company. We are witnessing a key moment in medical history... And this tiny biotech is leading the charge. Big Phamra giants are already pouring money into this stock. For instance: Biogen invested $1 billion... Sanofi invested $125 million... Japanese Big Pharma giant Takeda invested $150 million. Despite these huge partnerships, the company I'm talking about is still an underpriced micro-cap. These investments could catapult the stock to new heights in the near future... So if you want the chance to own the next big thing in biotech... Watch my exclusive report here >>> Sincerely, Samantha Tino, Editor Behind the Markets You are receiving this email as a part of your membership in The Oxford Club. Oxford Club Special Opportunities is published by The Oxford Club. To unsubscribe from opportunity based emails like this one, click here. Please note that this will not impact the fulfillment of your subscription in any way.. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist The Oxford Club Special Opportunities © 2024 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 1.800.589.3430 | International: +1.443.353.4334 | Fax: 1.410.329.1923 Oxfordclub.com Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.